The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution-Reference-Cited by-同舟云学术

The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

Published:2019-05-14 Issue:12 Volume:33 Page:2842-2853
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Singhal Deepak,Wee Li Yan A.,Kutyna Monika M.^ORCID,Chhetri Rakchha,Geoghegan Joel,Schreiber Andreas W.,Feng Jinghua,Wang Paul P.-S.,Babic Milena,Parker Wendy T.,Hiwase Smita,Edwards Suzanne,Moore Sarah^ORCID,Branford Susan,Kuzmanovic Teodora,Singhal Nimit,Gowda Raghu,Brown Anna L.,Arts Peer,To Luen B.,Bardy Peter G.,Lewis Ian D.,D’Andrea Richard J.,Maciejewski Jaroslaw P.,Scott Hamish S.,Hahn Christopher N.^ORCID,Hiwase Devendra K.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0479-8.pdf

Reference41 articles.

1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

2. Bhatia S. Therapy-related myelodysplasia and acute myeloid leukemia. Sem Oncol. 2013;40:666–75.

3. Ok CY, Hasserjian RP, Fox PS, Stingo F, Zuo Z, Young KH, et al. Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia. Leukemia. 2014;28:185–9.

4. Walter MJ, Shen D, Shao J, Ding L, White BS, Kandoth C, et al. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia. 2013;27:1275–82.

5. Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28:241–47.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms;Blood Cancer Journal;2024-04-09

2. Acute Myeloid Leukemia Post Cytotoxic Therapy in Breast Cancer Survivors—Over 23 Years of Single Center Analysis;Journal of Clinical Medicine;2024-02-08

3. CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature;Frontiers in Oncology;2024-01-25

4. Comparison of the 2022 World Health Organization Classification and International Consensus Classification in Myelodysplastic Syndromes/Neoplasms;2024-01-03

5. THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION;Mediterranean Journal of Hematology and Infectious Diseases;2023-10-30